Author Correction: Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment
Crossref DOI link: https://doi.org/10.1038/s41598-021-00539-5
Published Online: 2021-10-25
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shaughnessy, Ciaran A.
Zeitlin, Pamela L.
Bratcher, Preston E.
Text and Data Mining valid from 2021-10-25
Version of Record valid from 2021-10-25
Article History
First Online: 25 October 2021